Innovation, integration and efficiency for biomanufacturing leaders and partners
GLOBAL LEADERS
Our speakers come from across the globe and from all industry sectors. 2017 speakers include:
Professor Klaus Cichutek, President, Paul Ehrlich Institute
Klaus Cichutek is an extraordinary Professor of Biochemistry at the Goethe University Frankfurt/Main, and President of the Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, Germany. The Paul-Ehrlich-Institut is a Medicines Agency (veterinary and human vaccines, human...
Dr Hitto Kaufmann, Global Vice President of Biopharmaceutics Development, Sanofi Aventis Deutschland Germany Gmbh
Dr Kaufmann is currently the Global Vice President of Biopharmaceutical Development and Platform Innovation within Sanofi, and has previously held the role of Vice President Process Science Germany within the global biopharmaceutical division of Boehringer Ingelheim. Before this Dr. Kaufmann was...
Dr Mark Angelino, Senior Vice President, Pharmaceutical Sciences, bluebird bio
Dr. Angelino is SVP of Pharmaceutical Sciences at bluebird bio. He manages the development, analytical development/QC, and clinical manufacturing functions for both our lentiviral vector materials and autologous drug products. He was most recently at Baxter Healthcare for which he led their...
Dr Manuel Carrondo, Vice President, IBET
Chemical Engineer, 1971, Univ. Porto; Master of Sciences (1975) and Philosophy Doctor (1979) Environmental Engineering, Imperial College of Science and Technology, U. London; Habilitation, Biochemical Engineering (1991), Univ. Nova de Lisboa.Full Professor, Chemical and Biochemical...
Dr Helene Faustrup Kildegaard, Senior Researcher and Co PI, Technical University of Denmark
Helene Faustrup Kildegaard is Senior Researcher and co-Principal Investigator at the Novo Nordisk Foundation Center for Biosustainability at the Technical University of Denmark. She received her PhD degree in cellular and molecular biology from the Danish Cancer Society/Technical University of...
Dr Berthold Boedeker, Chief Scientist, Bayer Ag
Dr. Berthold Boedeker is Chief Scientist at Global Biologics-Biotech Development of Bayer Pharma AG in Wuppertal, Germany, which is responsible for the technical development and clinical material production of microbial and mammalian proteins. During his more than 30 years within the Bayer group he ...
Dr David Brindley, Senior Research Fellow in Healthcare Translation, Oxford University
Dr David Brindley is an international research and industrial leader in healthcare translation. He holds academic appointments at the University of Oxford, Harvard, UCL, Stanford-UCSF-FDA Centre for Regulatory Sciences and CASMI, and is an enthusiastic and diligent advisor to a portfolio of...
Dr Joey Studts, Global Bioprocess and Pharma Development, Boehringer Ingelheim Pharma GmbH & Co. KG
Dr. Joey Studts is currently Director of Late Stage Downstream Development in the BioPharmaceuticals Division at Boehringer Ingelheim Pharma GmbH in Biberach Germany. In this role, he is responsible for the development of purification processes, stage I validation, and transfer of therapeutic...
Dr Harald Bradl, Director Cell Culture Development, Boehringer Ingelheim Pharma GmbH & Co. KG
• Biologist by training (Studies biology at the University Erlangen-Nürnberg)• Joined BI in 2005 as Associate Director for In-Process Control in Cell Culture Manufacturing (GMP facility)• From 2010 -2013: Associate Director for Cell Culture Development (Responsibility for the development...
Dr Jean-René Authelin, Global Head of Pharmaceutical Engineering, Sanofi
Jean René Authelin has an Engineer degree in chemical Engineering from ENSIC (Nancy France), and a PhD from The Institut National Polytechnique de Lorraine (France). He joined Rhone Poulenc in 1988 as a Chemical Engineer. In the 90’s he founded the Physical Quality function, dedicated to the API...
Professor Klaus Cichutek
President
Paul Ehrlich Institute
Dr Hitto Kaufmann
Global Vice President of Biopharmaceutics Development
Regulation of CMC and Developability,
Manufacture & logistics
,
next generation therapeutics,
purification platforms,
novel platforms
,
next generation therapeutics,
advances in chromatography
,
advances in novel purification method
s,
PAT
,
process modelling,
monitoring and control
,
continuous manufacture,
CRISPR and cell line development,
quality control and analytics
,
media process development
Since 1988 the world’s leading brands have attended Terrapinn’s events. Established brands use our events to consolidate their position, grow their market share, or enter new sectors or territories. Challenger brands use our events to demonstrate thought leadership, establish their point of difference, and win over new customers.
The conference will help you:
Maintain and strengthen existing relationships with key clients and customers;
Demonstrate thought leadership, often through speaking positions;
Consolidate or raise the profile of their brand;
Generate new sales leads
All of these help our clients:
Enter a new territory or a new sector
Consolidate and strengthen an existing position against competition
Grow their market share
Help solve a public relations challenge
Talk to us today about
how we can help your business development, marketing and communications plan for 2017 and beyond.
DOWNLOAD THE PROSPECTUS
Download the prospectus to see a sample attendee list from 2016, sponsor and exhibition packages, the floor plan, sponsorship and networking opportunities and to see what our customers are saying.
DOWNLOAD THE PROSPECTUS
GET INVOLVED
To sponsor or exhibit contact:
Toby Lomax
Tel: +44 (0)20 7092 1249
email: toby.lomax@terrapinn.com
To speak, contact: Joan Shutt
Tel: +44 207 092 1134
email: joan.shutt@terrapinn.com